FULCRUM THERAPEUTICS
3.6100
07-October-24 13:01:36
15 minutes delayed
Stocks
-0.2100
-5.50%
Today's range
3.5700 - 3.7800
ISIN
N/A
Source
NASDAQ
-
Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results
08 Nov 2022 06:17:58 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer
07 Nov 2022 16:00:00 By Nasdaq GlobeNewswire
-
02 Nov 2022 06:05:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate at Upcoming November Investor Conferences
01 Nov 2022 16:29:02 By Nasdaq GlobeNewswire
-
12 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Oct 2022 16:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 Sep 2022 16:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming September Investor Conferences
06 Sep 2022 15:01:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate at the Upcoming Stifel 2022 Biotech Summer Summit
16 Aug 2022 06:05:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
15 Aug 2022 20:28:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
15 Aug 2022 15:08:15 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
11 Aug 2022 06:00:02 By Nasdaq GlobeNewswire
-
04 Aug 2022 07:07:44 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Aug 2022 07:00:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Departure of Chief Medical Officer
11 Jul 2022 16:00:00 By Nasdaq GlobeNewswire
-
05 Jul 2022 06:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jun 2022 15:02:00 By Nasdaq GlobeNewswire
-
10 Jun 2022 06:02:00 By Nasdaq GlobeNewswire